Progesterone receptor membrane component 1 deficiency attenuates growth while promoting chemosensitivity of human endometrial xenograft tumors

Endometrial cancer is the leading gynecologic cancer in women in the United States with 52,630 women predicted to be diagnosed with the disease in 2014. The objective of this study was to determine if progesterone (P4) receptor membrane component 1 (PGRMC1) influenced endometrial cancer cell viabili...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cancer Lett
Autores principales: Friel, Anne M., Zhang, Ling, Pru, Cindy A., Clark, Nicole C., McCallum, Melissa L., Blok, Leen J., Shioda, Toshi, Peluso, John J., Rueda, Bo R., Pru, James K.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4259802/
https://ncbi.nlm.nih.gov/pubmed/25304370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.canlet.2014.09.036
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares